About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The research conducted in our group is geared toward elucidating the cause and molecular mechanisms of neurodegeneration in Parkinson's disease (PD), a disabling, currently incurable common neurodegenerative disorder. To this end, we perform clinical and pre-clinical translational research in both PD patients and in human-relevant experimental in vitro and in vivo PD-related models.
Elucidating the molecular mechanisms underlying neurodegeneration in PD should allow to:
IP: Miquel Vila Bover
IP: Miquel Vila Bover, Ariadna Laguna Tuset
IP: Marta Martínez Vicente
IP: Miquel Vila Bover Collaborators: Núria Peñuelas Peñarroya, Miriam Izquierdo Sans Funding agency: Ministerio Economía, Industria y Competitividad Funding: 88250 Reference: BES-2017-080191 Duration: 01/07/2018 - 30/11/2022
IP: Marta Martínez Vicente Collaborators: Marta Montpeyó Garcia-Moreno, Miriam Izquierdo Sans , Laia Perez Lasarte Funding agency: Ministerio de Educación, Cultura y Deporte Funding: 49266 Reference: FPU18/05595 Duration: 15/10/2019 - 14/10/2022
IP: Marta Martínez Vicente Collaborators: Eddie Pradas Gracia, Laia Perez Lasarte Funding agency: Fundació Institut de Recerca HUVH Funding: 50649.27 Reference: VHIR/BEQUESPREDOC/2019/PRADAS Duration: 01/04/2020 - 31/03/2023
IP: Jordi Bove Badell Collaborators: Oriol de Fabregues-Boixar Nebot Funding agency: Instituto de Salud Carlos III Funding: 141570 Reference: PI18/01894 Duration: 01/01/2019 - 31/12/2022
IP: Miquel Vila Bover Collaborators: Joan Compte Barrón, Miriam Izquierdo Sans Funding agency: Fundació "La Caixa" Funding: 115092 Reference: CAIXA/INPHINIT/COMPTE Duration: 01/10/2018 - 30/09/2021
IP: Jordi Bove Badell Collaborators: Laia Perez Lasarte Funding agency: Fundación Tatiana Pérez de Guzmán el Bueno Funding: 94000 Reference: TATIANA/PREDOC/NEURO/2016/GALIANO Duration: 01/12/2016 - 31/12/2020
IP: Marta Martínez Vicente Collaborators: Jordi Riera Heredia, Laia Perez Lasarte Funding agency: Generalitat de Catalunya - Departament de Salut Funding: 67280.97 Reference: SLT006/17/00268 Duration: 12/03/2018 - 31/12/2020
IP: Miquel Vila Bover Collaborators: Jordi Bove Badell, Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 91125 Reference: CPII16/00029 Duration: 01/01/2017 - 31/12/2019
IP: Jordi Bove Badell Collaborators: Laia Perez Lasarte Funding agency: Generalitat de Catalunya - Departament de Salut Funding: 67280.97 Reference: SLT006/17/00258 Duration: 14/03/2018 - 12/05/2019
IP: Miquel Vila Bover Collaborators: Laia Perez Lasarte Funding agency: Ministerio de Educación, Cultura y Deporte Funding: 61544 Reference: FPU13/01339 Duration: 02/09/2014 - 31/01/2018
IP: Miquel Vila Bover Collaborators: Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 82400 Reference: FI14/00613 Duration: 01/01/2015 - 31/12/2018
IP: Miquel Vila Bover Collaborators: Marta Martínez Vicente, Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 101250 Reference: CPII15/00007 Duration: 01/01/2016 - 31/12/2018
IP: Marta Martínez Vicente Collaborators: Laia Perez Lasarte Funding agency: Ministerio Economía, Industria y Competitividad Funding: 86400 Reference: JCI-2012-13544 Duration: 15/09/2014 - 14/09/2017
IP: Miquel Vila Bover Collaborators: Jordi Bove Badell, Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 202500 Reference: MS11/00229 Duration: 01/01/2012 - 31/12/2016
IP: Miquel Vila Bover Collaborators: Ariadna Laguna Tuset, Laia Perez Lasarte Funding agency: AGAUR Funding: 91022.4 Reference: 2013 BP_B 00113 Duration: 01/10/2014 - 30/09/2016
IP: Miquel Vila Bover Collaborators: Marta Martínez Vicente, Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 243000 Reference: MS09/00184 Duration: 01/01/2010 - 31/12/2015
IP: Miquel Vila Bover Collaborators: Laia Perez Lasarte Funding agency: AGAUR Funding: 30000 Reference: 2011FI_B 00575 Duration: 01/02/2011 - 31/01/2014
IP: - Collaborators: Annabelle Parent Funding agency: Instituto de Salud Carlos III Funding: 160325 Reference: PI09/00255 Duration: 01/01/2010 - 31/12/2013
IP: Miquel Vila Bover Collaborators: Laia Perez Lasarte Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 180400 Reference: RYC-2005-1561 Duration: 12/07/2006 - 31/10/2011
IP: Miquel Vila Bover Collaborators: Jordi Bove Badell Funding agency: Instituto de Salud Carlos III Funding: 217679 Reference: PI071019 Duration: 01/01/2008 - 30/06/2011
IP: Miquel Vila Bover Collaborators: Jordi Bove Badell Funding agency: EUROPEAN COMMISSION Funding: 1151774.03 Reference: FP6-PEOPLE-PCD-IN-PD-24929 Duration: 01/12/2005 - 01/12/2009
IP: Miquel Vila Bover Collaborators: - Funding agency: Fundació Bancària "la Caixa" Funding: 90000 Reference: BM06-153-0 Duration: 01/01/2007 - 31/12/2009
IP: Miquel Vila Bover Collaborators: - Funding agency: EUROPEAN COMMISSION Funding: 80000 Reference: MIRG-CT-2004-006505 Duration: 13/10/2005 - 13/10/2007
PMID: 35805133 Journal: Cells Year: 2022 Reference: Cells. 2022 Jun 28;11(13). pii: cells11132046. doi: 10.3390/cells11132046. Impact factor: 6.6 Publication type: Paper in international publication Authors: Rodriguez-Urrutia, Amanda, Torres, Ines de, Santos-Briones, Ignacio, Azpiroz, Fernando, Lobo, Beatriz, Alonso-Cotoner, Carmen, Santos, Javier, Gonzalez-Castro, Ana M, Vicario, Maria, Guagnozzi, Danila et al. DOI: 10.3390/cells11132046
PMID: 35626681 Journal: Cells Year: 2022 Reference: Cells. 2022 May 14;11(10). pii: cells11101644. doi: 10.3390/cells11101644. Impact factor: 6.6 Publication type: Review in international publication Authors: Salvo-Romero, Eloisa, Rodino-Janeiro, Bruno K, Albert-Bayo, Merce, Lobo, Beatriz, Santos, Javier, Farre, Ricard, Martinez, Cristina, Vicario, Maria et al. DOI: 10.3390/cells11101644
PMID: 35429504 Journal: NEUROPHARMACOLOGY Year: 2022 Reference: Neuropharmacology. 2022 Jul 1;212:109058. doi: 10.1016/j.neuropharm.2022.109058. Epub 2022 Apr 13. Impact factor: 5.251 Publication type: Paper in international publication Authors: Gonzalez-Sepulveda, Marta, Omar, Muhammad Yusof, Hamdon, Sally, Ma, Guofen, Rosell-Vilar, Santi, Raivio, Noora, Abass, Doaa, Martinez-Rivas, Anna, Vila, Miquel, Giraldo, Jesus et al. DOI: 10.1016/j.neuropharm.2022.109058
PMID: 34794916 Journal: Revista Espanola de Medicina Nuclear e Imagen Molecular Year: 2022 Reference: Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Jan-Feb;41(1):52-54. doi: 10.1016/j.remnie.2021.05.002. Epub 2021 Nov 16. Impact factor: 1.359 Publication type: Letter or abstract Authors: Carrillo-Villamizar, E, Cardozo-Saavedra, A, Lorenzo-Bosquet, C, Lucas Del Pozo, S, Martinez-Saez, E, Hernandez-Vara, J et al. DOI: 10.1016/j.remnie.2021.05.002
PMID: 34778332 Journal: Frontiers in Nutrition Year: 2021 Reference: Front Nutr. 2021 Oct 28;8:718093. doi: 10.3389/fnut.2021.718093. eCollection 2021. Impact factor: 6.576 Publication type: Review in international publication Authors: Fortea, Marina, Albert-Bayo, Merce, Abril-Gil, Mar, Ganda Mall, John-Peter, Serra-Ruiz, Xavier, Henao-Paez, Alejandro, Exposito, Elba, Gonzalez-Castro, Ana Maria, Guagnozzi, Danila, Lobo, Beatriz et al. DOI: 10.3389/fnut.2021.718093
PMID: 33986284 Journal: npj Parkinsons Disease Year: 2021 Reference: NPJ Parkinsons Dis. 2021 May 13;7(1):40. doi: 10.1038/s41531-021-00184-9. Impact factor: 8.651 Publication type: Paper in international publication Authors: Yanes, Oscar, Laguna, Ariadna, Xicoy, Helena, Tolosa, Eduardo, Serradell, Monica, Vilas, Dolores, Gaig, Carles, Fernandez, Manel, Iranzo, Alex, Vila, Miquel et al. DOI: 10.1038/s41531-021-00184-9
PMID: 33875401 Journal: Revista Espanola de Medicina Nuclear e Imagen Molecular Year: 2021 Reference: Rev Esp Med Nucl Imagen Mol (Engl Ed). 2021 Apr 16. pii: S2253-654X(21)00057-3. doi: 10.1016/j.remn.2021.02.015. Impact factor: 1.359 Publication type: Letter or abstract Authors: Hernandez-Vara, J, Martinez-Saez, E, Lucas Del Pozo, S, Cardozo-Saavedra, A, Carrillo-Villamizar, E, Lorenzo-Bosquet, C et al. DOI: 10.1016/j.remn.2021.02.015
PMID: 33738725 Journal: ADVANCES IN THERAPY Year: 2021 Reference: Adv Ther. 2021 May;38(5):2054-2076. doi: 10.1007/s12325-021-01676-z. Epub 2021 Mar 18. Impact factor: 3.847 Publication type: Review in international publication Authors: Alonso-Cotoner, Carmen, Abril-Gil, Mar, Albert-Bayo, Merce, Mall, John-P Ganda, Exposito, Elba, Gonzalez-Castro, Ana M, Lobo, Beatriz, Santos, Javier et al. DOI: 10.1007/s12325-021-01676-z
PMID: 33147750 Journal: Cells Year: 2020 Reference: Cells. 2020 Nov 2;9(11). pii: cells9112399. doi: 10.3390/cells9112399. Impact factor: 4.366 Publication type: Review in international publication Authors: Navarro-Romero, Alba, Montpeyo, Marta, Martinez-Vicente, Marta et al. DOI: 10.3390/cells9112399
PMID: 33118032 Journal: BRAIN Year: 2020 Reference: Brain. 2020 Dec 1;143(12):3717-3733. doi: 10.1093/brain/awaa269. Impact factor: 11.337 Publication type: Paper in international publication Authors: Galiano-Landeira, Jordi, Torra, Albert, Vila, Miquel, Bove, Jordi et al. DOI: 10.1093/brain/awaa269
PMID: 32786306 Journal: ACS Chemical Neuroscience Year: 2020 Reference: ACS Chem Neurosci. 2020 Sep 2;11(17):2679-2687. doi: 10.1021/acschemneuro.0c00336. Epub 2020 Aug 24. Impact factor: 4.486 Publication type: Paper in international publication Authors: Nicolau, Alba, Guillard-Sirieix, Camille, Xicoy, Helena, Kobayashi, Jumpei, Vila, Miquel, Compte, Joan, Penuelas, Nuria, Cuadros, Thais, Gonzalez-Sepulveda, Marta, Laguna, Ariadna et al. DOI: 10.1021/acschemneuro.0c00336
PMID: 32682292 Journal: PARKINSONISM & RELATED DISORDERS Year: 2020 Reference: Parkinsonism Relat Disord. 2020 Sep;78:31-35. doi: 10.1016/j.parkreldis.2020.06.037. Epub 2020 Jul 4. Impact factor: 3.926 Publication type: Paper in international publication Authors: Lucas-Del Pozo, S, Carter, S, Armengol-Bellapart, M, Castell-Conesa, J, Cuberas-Borros, G, Corominas-Roso, M, Lorenzo-Bosquet, C, Saez-Francas, N, Hernandez-Vara, J et al. DOI: 10.1016/j.parkreldis.2020.06.037
PMID: 31731485 Journal: Cells Year: 2019 Reference: Cells. 2019 Oct 25;8(11). pii: cells8111317. doi: 10.3390/cells8111317. Impact factor: 5.656 Publication type: Review in international publication Authors: Xicoy, Helena, Penuelas, Nuria, Vila, Miquel, Laguna, Ariadna et al. DOI: 10.3390/cells8111317
PMID: 30846695 Journal: Nature Communications Year: 2019 Reference: Nat Commun. 2019 Mar 7;10(1):973. doi: 10.1038/s41467-019-08858-y. Impact factor: 11.878 Publication type: Paper in international publication Authors: Gonzalez-Sepulveda, Marta, Penuelas, Nuria, Torra, Albert, Rodriguez-Galvan, Beatriz, Ballabio, Andrea, Hasegawa, Takafumi, Bortolozzi, Analia, Gelpi, Ellen, Vila, Miquel, Parent, Annabelle et al. DOI: 10.1038/s41467-019-08858-y
PMID: 30744042 Journal: Cells Year: 2019 Reference: Cells. 2019 Feb 8;8(2). pii: cells8020135. doi: 10.3390/cells8020135. Impact factor: 5.656 Publication type: Review in national publication Authors: Albert-Bayo, Merce, Paracuellos, Irene, Gonzalez-Castro, Ana M, Rodriguez-Urrutia, Amanda, Rodriguez-Lagunas, Maria J, Alonso-Cotoner, Carmen, Santos, Javier, Vicario, Maria et al. DOI: 10.3390/cells8020135
PMID: 30415891 Journal: EBioMedicine Year: 2019 Reference: EBioMedicine. 2019 Jan;39:497-509. doi: 10.1016/j.ebiom.2018.10.071. Epub 2018 Nov 8. Impact factor: 6.68 Publication type: Paper in international publication Authors: Gosalbes, Maria Jose, Compte, Joan, Moriano-Gutierrez, Silvia, Valles, Yvonne, Jimenez-Hernandez, Nuria, Pons, Xavier, Artacho, Alejandro, Francino, M Pilar et al. DOI: 10.1016/j.ebiom.2018.10.071
PhD student: Jordi Galiano Landeira Director/s: Jordi Bove Badell University: Universitat Autònoma de Barcelona Year: 2021
PhD student: Director/s: Jordi Bove Badell, Miquel Vila Bover University: Universitat Autònoma de Barcelona Year: 2019
PhD student: Albert Torra i Talavera Director/s: Jordi Bove Badell, Miquel Vila Bover University: Universitat Autònoma de Barcelona Year: 2019
PhD student: Sandra Franco Iborra Director/s: Miquel Vila Bover University: Universitat Autònoma de Barcelona Year: 2018
PhD student: Oriol de Fabregues-Boixar Nebot Director/s: Francesc Miquel Rodriguez, Miquel Vila Bover University: Universitat Autònoma de Barcelona Year: 2016
La primera jornada dedicada a aquesta malaltia organitzada pel Campus Vall d’Hebron ha reunit més de 150 assistents.
As of tomorrow, Lleida will be hosting the 19th Congress of the Spanish Society of Neuroscience (SENC). This is a biennial event, which this year will be held from 3 to 5 November in la Llotja, the Lleida Exhibition Centre.
The Aligning Science Across Parkinson's (ASAP) initiative has awarded the grant to a project coordinated by Dr. Miquel Vila, head of the Neurodegenerative Diseases research group at the Vall d'Hebron Research Institute (VHIR).
